AbbVie Cuts Q3, FY Adj. EPS Outlook
I'm PortAI, I can summarize articles.
AbbVie Inc. has revised its adjusted earnings per share (EPS) outlook for Q3 and FY 2024 downwards due to acquisition-related expenses. The company now expects Q3 adjusted EPS to be between $0.88 and $0.92, down from $0.92 to $0.96, while the full-year forecast is adjusted to $0.67 to $0.87 from $0.71 to $0.91. Analysts had previously estimated Q3 earnings at $0.95 and full-year earnings at $0.88 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments